In 3xTg-AD mice, dietary SAMe supplementation reduced hippocampal Aβ and phosphorylated tau, and delayed the accumulation of extracellular Aβ, demonstrating SAMe’s ability to modulate the time course of AD neuropathology (21, 23). This evidence concerns the gene MAPT and Alzheimer disease.